Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
21.00
-0.45 (-2.10%)
Oct 30, 2026, 9:32 AM EDT - Market open
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $152.55 million as of October 30, 2026. It is the 22,172nd most valuable company in the world and the 3,786th biggest in the United States. Its market cap has increased by 187.84% in one year.
Market Cap
152.55M
Enterprise Value
138.22M
1-Year Change
187.84%
Global Rank
Country Rank
#3,786 United States
Category
ChartMarket Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $193.50M to $152.55M, a decrease of -21.16%. That is a compound annual growth rate of -2.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 152.55M | 535.64% |
| Dec 31, 2025 | 24.00M | -65.27% |
| Dec 31, 2024 | 69.10M | -41.98% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atrium Therapeutics | 142.32M |
| Jyong Biotech | 141.79M |
| Veraxa Biotech AG | 141.37M |
| Codexis | 140.17M |
| Compass Therapeutics | 134.60M |
| TuHURA Biosciences | 134.46M |
| Innate Pharma | 132.80M |
| Spruce Biosciences | 131.20M |